69 related articles for article (PubMed ID: 19804294)
41. Cardiovascular protection by angiotensin-converting enzyme 2: a new paradigm.
Ferreira AJ; Hernández Prada JA; Ostrov DA; Raizada MK
Future Cardiol; 2008 Mar; 4(2):175-82. PubMed ID: 19804294
[TBL] [Abstract][Full Text] [Related]
42. Role of ACE2 in diastolic and systolic heart failure.
Wang W; Bodiga S; Das SK; Lo J; Patel V; Oudit GY
Heart Fail Rev; 2012 Sep; 17(4-5):683-91. PubMed ID: 21638102
[TBL] [Abstract][Full Text] [Related]
43. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases.
Parajuli N; Ramprasath T; Patel VB; Wang W; Putko B; Mori J; Oudit GY
Can J Physiol Pharmacol; 2014 Jul; 92(7):558-65. PubMed ID: 24861775
[TBL] [Abstract][Full Text] [Related]
44. Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy.
Oudit GY; Penninger JM
Curr Heart Fail Rep; 2011 Sep; 8(3):176-83. PubMed ID: 21611889
[TBL] [Abstract][Full Text] [Related]
45. Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure.
Patel VB; Putko B; Wang Z; Zhong JC; Oudit GY
Drug Discov Today Ther Strateg; 2012; 9(4):e141-e148. PubMed ID: 32362932
[TBL] [Abstract][Full Text] [Related]
46. ACE2: a new target for cardiovascular disease therapeutics.
Raizada MK; Ferreira AJ
J Cardiovasc Pharmacol; 2007 Aug; 50(2):112-9. PubMed ID: 17703127
[TBL] [Abstract][Full Text] [Related]
47. [The importance of ACE2 in regulating the cardiovascular system].
Raz A; Gamliel-Lazarovich A; Bogner I; Strigevsky A; Keidar S
Harefuah; 2007 Sep; 146(9):703-6, 733. PubMed ID: 17969309
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonist.
Santos RA; Ferreira AJ
Cardiovasc Drug Rev; 2006; 24(3-4):239-46. PubMed ID: 17214600
[TBL] [Abstract][Full Text] [Related]
49. Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications.
Patel VB; Parajuli N; Oudit GY
Clin Sci (Lond); 2014 Apr; 126(7):471-82. PubMed ID: 24329564
[TBL] [Abstract][Full Text] [Related]
50. Angiotensin-converting enzyme 2 as a therapeutic target for heart failure.
Chamsi-Pasha MA; Shao Z; Tang WH
Curr Heart Fail Rep; 2014 Mar; 11(1):58-63. PubMed ID: 24293035
[TBL] [Abstract][Full Text] [Related]
51. ACE2 and diabetic complications.
Dean RG; Burrell LM
Curr Pharm Des; 2007; 13(26):2730-5. PubMed ID: 17897017
[TBL] [Abstract][Full Text] [Related]
52. Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling.
McKinney CA; Fattah C; Loughrey CM; Milligan G; Nicklin SA
Clin Sci (Lond); 2014 Jun; 126(12):815-27. PubMed ID: 24593683
[TBL] [Abstract][Full Text] [Related]
53. The ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Pleiotropic Roles in Cancer.
Xu J; Fan J; Wu F; Huang Q; Guo M; Lv Z; Han J; Duan L; Hu G; Chen L; Liao T; Ma W; Tao X; Jin Y
Front Physiol; 2017; 8():276. PubMed ID: 28533754
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
